Tissue Repair

Tissue Repair Book Value per Share

The Book Value per Share of Tissue Repair (TRP.AX) as of Oct 27, 2026 is 0.15 AUD. In the previous year, Book Value per Share was 0.23 AUD — a change of -36.92% (lower).

Book Value per Share

0.15AUD

YoY

-36.92%

Last updated:

Book Value per Share of Tissue Repair is 2026 0.15 AUD. Book Value per Share of Tissue Repair was 2025 0.23 AUD. It decreases by -36.92% lower compared to the previous year.

The Tissue Repair Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.02 AUD
Jan 1, 2021
0.45 AUD
Jan 1, 2022
0.42 AUD
Jan 1, 2023
0.36 AUD
Jan 1, 2024
0.30 AUD
Jan 1, 2025
0.23 AUD
Jan 1, 2026
0.15 AUD
The Tissue Repair Book Value per Share history
YEARBook Value per ShareYoY
0.15AUD-36.92%
0.23AUD-22.88%
0.30AUD-17.56%
0.36AUD-13.64%
0.42AUD-6.41%
0.45AUD+2,607.56%
0.02AUD+669.16%
0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tissue Repair Stock analysis

What does Tissue Repair do? Tissue Repair Ltd. develops advanced wound healing products for chronic wounds and post-cosmetic procedure care. The company is in the final stages of completing its Phase II program for TR-987, a chronic wound product, and concluded Phase IIB trials on Glucoprime, a proprietary molecule. TR Pro+ is the firm's cosmeceutical post-procedure gel product used in minimally invasive cosmetic procedures, currently focused on commercialization. The company's revenue streams include product development for TR-987, Glucoprime, and TR Pro+. Tissue Repair Ltd. targets healthcare providers and cosmetic clinics as key buyers of its products. Healthcare providers use TR-987 for chronic wound management, while cosmetic clinics utilize TR Pro+ for post-procedure care. The firm's focus on commercialization of TR Pro+ indicates a direct sales approach to these segments. The company's pipeline includes TR-987, Glucoprime, and TR Pro+ as its core products. The firm's products are developed for specific medical and cosmetic segments. TR-987 addresses chronic wound healing, a significant healthcare need, while Glucoprime is a proprietary molecule with potential for further development. TR Pro+ serves the growing cosmeceutical market for post-procedure care. The company's business model relies on advancing its pipeline through clinical trials and commercializing its products to target healthcare and cosmetic markets. Tissue Repair is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tissue Repair stock

Book Value per Share of Tissue Repair is 0.15 AUD in 2026.

Book Value per Share of Tissue Repair changed from 0.23 AUD to 0.15 AUD, representing a -36.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Tissue Repair since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Tissue Repair

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Tissue Repair